Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(58 sites)
United States
Mayo Clinic, Phoenix, Arizona Honor Health Research Institute, Scottsdale, Arizona City of Hope National Medical Center, Duarte, California UC San Diego Moores Cancer Center, La Jolla, California UCLA Hematology/Oncology, Los Angeles, California UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California Stanford Cancer Center, Stanford, California Yale Cancer Center, New Haven, Connecticut Mayo Clinic Florida, Jacksonville, Florida University of Miami - Sylvester Comprehensive Cancer Cente, Miami, Florida Moffitt Cancer Center, Tampa, Florida University of Chicago Medical Center, Chicago, Illinois University of MD Greenebaum Comprehensive Cancer Center, Baltimore, Maryland Massachusetts General Hospital, Boston, Massachusetts Beth Israel Deaconess Medical Center, Boston, Massachusetts University of Michigan, Ann Arbor, Michigan Mayo Clinic, Rochester, Minnesota University of Nebraska Medical Center, Omaha, Nebraska Atlantic Health System/Morristown Medical Center, Morristown, New Jersey Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York Memorial Sloan Kettering Cancer Center, New York, New York University of Rochester, Rochester, New York UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio Ohio State University, Columbus, Ohio Providence Cancer Institute Franz Clinic, Portland, Oregon University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania Thomas Jeffersion University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania Fox Chase Cancer Center, Philadelphia, Pennsylvania UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania Avera Cancer Institute, Sioux Falls, South Dakota SCRI Oncology Partners, Nashville, Tennessee Baylor University, Dallas, Texas University of Texas Southwestern Medical Center, Dallas, Texas The University of Texas MD Anderson Cancer Center, Houston, Texas Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah Virginia Commonwealth University, Richmond, Virginia Fred Hutchinson Cancer Center, Seattle, Washington Canada
BC Cancer - Vancouver, Vancouver, British Columbia University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario Germany
Universitatsklinikum Koeln, Cologne, Northrhine-W Estphalia Charite Universitaetsmedizin Berlin KöR, Berlin Universitaetsklinikum Bonn AöR, Bonn Technische Universitaet Dresden, Dresden Universitaetsklinikum Erlangen AöR, Erlangen Universitaetsklinikum Essen AöR, Essen Goethe University Frankfurt, Frankfurt am Main University Medical Center Hamburg-Eppendorf, Hamburg Universitaetsklinikum Heidelberg AöR, Heidelberg Universitaet Leipzig, Leipzig Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Mainz United Kingdom
Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge Greater Glasgow and Clyde NHS, Beatson West of Scotland Cancer Center, Glasgow Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London The Royal Marsden NHS Foundation Trust, London The Christie NHS Foundation Trust, Manchester Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford University of Southampton NHS Foundation Trust, Southampton General Hospital, Southampton